Repro-Med Systems, Inc. Forecast, price target & analysts
Repro-Med Systems, Inc. Target price 2026 - Analyst rating & recommendation
Repro-Med Systems, Inc. Classifications & Recommendation
Repro-Med Systems, Inc. Price Target
| Target Price | $6.12 |
| Price | $3.20 |
| Potential |
91.25%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Repro-Med Systems, Inc. 2027 .
The average Repro-Med Systems, Inc. target price is $6.12.
This is
91.25%
register free of charge
$8.40
162.50%
register free of charge
$5.05
57.81%
register free of charge
|
|
| A rating was issued by 10 analysts: 8 Analysts recommend Repro-Med Systems, Inc. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Repro-Med Systems, Inc. stock has an average upside potential 2027 of
91.25%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 41.13 | 49.01 |
| 22.23% | 19.15% | |
| EBITDA Margin | -5.25% | 3.92% |
| 68.22% | 174.64% | |
| Net Margin | -6.42% | -3.65% |
| 64.42% | 43.13% |
7 Analysts have issued a sales forecast Repro-Med Systems, Inc. 2026 . The average Repro-Med Systems, Inc. sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Repro-Med Systems, Inc. EBITDA forecast 2026. The average Repro-Med Systems, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Repro-Med Systems, Inc. Analysts have issued a net profit forecast 2026. The average Repro-Med Systems, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.06 | -0.04 |
| 53.85% | 33.33% | |
| P/E | negative | |
| EV/Sales | 2.85 |
7 Analysts have issued a Repro-Med Systems, Inc. forecast for earnings per share. The average Repro-Med Systems, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Repro-Med Systems, Inc....
Current Repro-Med Systems, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| B. Riley Securities |
Locked
➜
Locked
|
Locked | Mar 13 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Mar 13 2026 |
| Lake Street |
Locked
➜
Locked
|
Locked | Dec 22 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Dec 17 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | May 08 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Feb 14 2025 |
| Craig-Hallum |
Locked
➜
Locked
|
Locked | Jan 17 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
B. Riley Securities:
Locked
➜
Locked
|
Mar 13 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Mar 13 2026 |
|
Locked
Lake Street:
Locked
➜
Locked
|
Dec 22 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Dec 17 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
May 08 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Feb 14 2025 |
|
Locked
Craig-Hallum:
Locked
➜
Locked
|
Jan 17 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
